Herbalife, Allergan Lead To Questions Over Ackman Strategy

By Kaitlyn Kiernan (July 25, 2014, 6:07 PM EDT) -- Bill Ackman's career as an activist investor has been distinguished by impressive wins and huge losses, but the number of bets falling into the latter category has been on the rise as he has shown a bias for more aggressive plays that some experts say set management on the defensive and cast a pall over all activist investors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!